Response of interleukin‐6‐deficient mice to tumor necrosis factor‐induced metabolic changes and lethality
- 1 September 1994
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 24 (9) , 2237-2242
- https://doi.org/10.1002/eji.1830240945
Abstract
Whether interleukin (IL)-6 contributes to tumor necrosis factor (TNF)-induced lethal shock or whether, on the contrary, it is part of a protective feedback system, remains unresolved. Here, we report experiments with IL-6 gene-disrupted mice (IL-60/0). We have tested the susceptibility of these to TNF-induced metabolic changes and lethality in different models, and compared the results with those obtained with IL-6+/+ wild-type mice. We studied the response to TNF in three different models: (i) murine TNF administration; (ii) TNF in galactosamine (GalN)-sensitized mice; (iii) TNF in Bacillus Calmette-Guérin-sensitized mice. We observed no significant difference between the two types of mice in any of the three models. Furthermore, IL-60/0 mice could be equally well desensitized (by IL-1) to TNF/GalN-induced lethality and tolerized to TNF-induced shock as IL-6+/+ mice. We also observed that, in response to turpentine, TNF or IL-1, IL-60/0 mice produced significantly less acute phase proteins (APP) than IL-6+/+ mice. In IL-60/0 mice, less corticosterone was induced by TNF than in the control mice, while the response to adrenocorticotropic hormone was the same. The results indicate that IL-6 is not contributing in a major way to the pathogenesis leading to TNF-induced shock, and that neither IL-6 nor the APP studied are essential for a protective feedback system.Keywords
This publication has 29 references indexed in Scilit:
- Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytesPublished by Wiley ,2001
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- The acute phase responseImmunology Today, 1994
- The alphas, betas, and kinases of cytokine receptor complexesCell, 1993
- Cyclooxygenase Inhibitors Prevent the Induction of Tolerance to the Toxic Effects of Tumor Necrosis FactorJournal of Immunotherapy, 1993
- Protective effect of anti‐interleukin (IL)‐6 antibody against endotoxin, associated with paradoxically increased IL‐6 levelsEuropean Journal of Immunology, 1992
- Solid Phase Enzyme Immunoassays for the Quantification of Serum Amyloid P (SAP) and Complement Component 3 (C3) Proteins in Acute-Phase Mouse SeraHormone and Metabolic Research, 1992
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992
- The Influence of Modulating Substances on Tumor Necrosis Factor and Interleukin-6 Levels After Injection of Murine Tumor Necrosis Factor or Lipopolysaccharide in MiceJournal of Immunotherapy, 1991
- Interleukin-6: An OverviewAnnual Review of Immunology, 1990